Board Member
Assembly Biosciences, Inc. (ASMB)Chief Accounting Officer
Ironwood Pharmaceuticals Inc (IRWD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Gina Consylman is recorded as Board Member at Assembly Biosciences, Inc. (ASMB) and Chief Accounting Officer at Ironwood Pharmaceuticals Inc (IRWD). Assembly Biosciences, Inc. reported in an 8-K filed June 5, 2026 that Gina Consylman was appointed Director, effective June 4, 2026. Assembly Biosciences, Inc. reported in an 8-K filed June 3, 2024 that Gina Consylman was appointed Director, effective May 29, 2024. Assembly Biosciences, Inc. reported in an 8-K filed May 30, 2023 that Gina Consylman was appointed Director, effective May 25, 2023. Gina Consylman has spoken on 4 earnings calls across 1 company, most recently for Ironwood Pharmaceuticals Inc on May 6, 2021.
“The stockholders elected of the following to serve on the Company's Board of Directors until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified: Anthony E. Altig; Tomas Cihlar, Ph.D.; Gina Consylman; Robert D. Cook II; Sir Michael Houghton, Ph.D.; Lisa R. Johnson-Pratt, M.D.; Susan Mahony, Ph.D.; John G. McHutchison, A.O., M.D.; and Jason A. Okazaki.”
“William R. Ringo, Jr., Anthony E. Altig, Tomas Cihlar, Ph.D., Gina Consylman, Robert D. Cook II, Sir Michael Houghton, Ph.D., Lisa R. Johnson-Pratt, M.D., Susan Mahony, Ph.D., John G. McHutchison, A.O., M.D. and Jason A. Okazaki were each elected to serve on the Company's Board of Directors until the Company's 2025 annual meeting of stockholders and until their successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2026-06-04–present
2021-02-19–present
Start not stated–2021-07-02
Recorded roles and call appearances connecting this person to public companies.
Chief Accounting Officer
2021-02-19–present
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
